Skip to main content

After FDA Warning, Kim Kardashian Posts Corrected Endorsement Of Morning Sickness Pill

Kim Kardashian issued a corrected endorsement for morning sickness pill after the FDA took issue with a first post's lack of acknowledgement of associated safety risks.

Kim Kardashian issued a corrected endorsement for morning sickness pill after the FDA took issue with a first post’s lack of acknowledgement of associated safety risks.

Weeks after federal regulators took issue with drug company Duchesnay for allowing mom-to-be Kim Kardashian to tout the benefits of its morning sickness pill on social media without properly disclosing the drug’s associated risk and limitations, the reality star posted updated endorsements, complete with acknowledgement of the pill’s side effects.

The new “#CorrectiveAd” posts – which were quickly pushed down the page thanks to Kardashian’s posts about the MTV Video Music Awards – were mandated by the FDA after the agency issued a warning letter to Duchesnay in early August saying the lack of safety information included in Kardashian’s original July posts put consumers at risk.

“I guess you saw the attention my last #morningsickness post received,” an Instagram post from the celebrity states. “The FDA has told Duchesnay, Inc., that my last post about Diclegis (doxylamine succinate and pyridoxine HCl) was incomplete because it did not include any risk information or important limitations of use for Diclegis. A link to this information accompanied the post, but this didn’t meet FDA requirements. So, I’m re-posting and sharing this important information about Diclegis.”

According to the FDA letter, a review of the first endorsements by Kardashian found the posts to be “false or misleading in that it presents efficacy claims for Diclegis, but fails to communicate any risk information associated with its use and it omits material facts.”

As a result, the FDA claims the post misbrands the pill, which makes its distribution a violation of the Federal Food, Drug, and Cosmetic Act.

Regulators told Duchesnay that the misleading messages – which were quickly deleted by Kardashian in August – be corrected in the same format they were originally posted – meaning on Instagram, Twitter and Facebook.

While the first posts included a link to the company’s website and Duchesnay sent out a press release providing more details about the partnership including information on Diclegis, the FDA claimed those steps weren’t enough to mitigate misinformation.

Kardashian addressed those issue in her corrected ads on Sunday. The rather lengthy post goes on to include limitations – “Diclegis has not been studied in women with hyperemesis gravidarum” – and important safety information including a number of other medications that shouldn’t be taken in conjunction with the pill.

Here’s the full text of the corrected ad:

#CorrectiveAd I guess you saw the attention my last #morningsickness post received. The FDA has told Duchesnay, Inc., that my last post about Diclegis (doxylamine succinate and pyridoxine HCl) was incomplete because it did not include any risk information or important limitations of use for Diclegis. A link to this information accompanied the post, but this didn’t meet FDA requirements. So, I’m re-posting and sharing this important information about Diclegis. For US Residents Only.

Diclegis is a prescription medicine used to treat nausea and vomiting of pregnancy in women who have not improved with change in diet or other non-medicine treatments.
Limitation of Use: Diclegis has not been studied in women with hyperemesis gravidarum.

Important Safety Information
Do not take Diclegis if you are allergic to doxylamine succinate, other ethanolamine derivative antihistamines, pyridoxine hydrochloride or any of the ingredients in Diclegis. You should also not take Diclegis in combination with medicines called monoamine oxidase inhibitors (MAOIs), as these medicines can intensify and prolong the adverse CNS effects of Diclegis.

The most common side effect of Diclegis is drowsiness. Do not drive, operate heavy machinery, or other activities that need your full attention unless your healthcare provider says that you may do so. Do not drink alcohol, or take other central nervous system depressants such as cough and cold medicines, certain pain medicines, and medicines that help you sleep while you take Diclegis. Severe drowsiness can happen or become worse causing falls or accidents.

Tell your healthcare provider about all of your medical conditions, including if you are breastfeeding or plan to breastfeed. Diclegis can pass into your breast milk and may harm your baby. You should not breastfeed while using Diclegis.

Additional safety information can be found at http://ift.tt/1DprUH2 or http://www.Diclegis.com. Duchesnay USA encourages you to report negative side effects of prescription drugs to the FDA. Visit http://ift.tt/xNUY9D or call 1-800-FDA-1088.”

[via Bloomberg]


by Ashlee Kieler via Consumerist

Comments

Popular posts from this blog

Chrysler Deletes Its Dating Apps, Decides To Remain Single For Now

They say you can’t have a healthy relationship until you’re happy with yourself. That appears to be the new mantra for Fiat Chrysler: After several attempts to woo General Motors and more recently Volkswagen , the carmaker’s top executive says he plans to ditch his lovelorn ways to concentrate on his company’s bottom line.  Bloomberg reports that CEO Sergio Marchionne has turned his focus to eliminating FCA’s debt rather than eliminating its single status. Marchionne has set a goal of erasing FCA’s debt by 2019, the same year he’s set to retire. To do that, he says the company needs to do a little work on itself. “We need to be very careful that we don’t start unrealistic dreams about consolidation as we are on our way to achieve historically important results and a debt-free position,” Marchionne told investors at the carmaker’s annual meeting in Amsterdam, as reported by Bloomberg. “We are not at a point of time to discuss any alliance.” Yes, you heard that right: The man w...

Study Claims 43% Of “Wild” Salmon In Stores & Restaurants Isn’t Wild At All

That wild salmon entrée calling to you from the menu at dinner might not be all it’s advertised. In fact a new study released Wednesday found evidence of mislabeling in nearly half of all salmon sold in restaurants and grocery stores.  The study [ PDF ] from international environmental advocacy group, Oceana, analyzed 82 salmon samples from restaurants and grocery stores, finding that 43% of the products were mislabeled. DNA testing confirmed that 69% of the mislabeled product consisted of farmed Atlantic salmon being sold as wild-caught product. According to the report, consumers satisfying their salmon craving in restaurants are misled about 67% of the time, while those who buy their seafood in a grocery store are misled 20% of the time. “Americans might love salmon, but as our study reveals, they may be falling victim to a bait and switch,” Beth Lowell, senior campaign director at Oceana, said . “When consumers opt for wild-caught U.S. salmon, they don’t expect to get a far...

Introduction to Biology (IX Biology Notes Chapter 01)

Science: Our universe operates under certain principles. For understanding of these principles, the experiments are done and observations are made; on the basis of which logical conclusions are drawn. Such a study is called "Science". In brief science is the knowledge based on experiments and observations. Biology: The Scientific study of living organisms is called Biology. The word biology is derived from two Greek words "bios" meaning life and "logos" meaning thought, discourse, reasoning or study. It means that all aspects of life and every type of living organism are discussed in biology. Branches of Biology: Biology is divided into following branches: Morphology The study of form and structure of living organisms is called morphology. It can be further divided into following two parts: 1. The study of external parts of living organism is called external morphology. 2. The study of internal parts of living organism is calle...